CHICAGO, Illinois — A commercially available food supplement that
contains pomegranate, broccoli, green tea, and turmeric significantly
lowers prostate-specific antigen (PSA) levels, compared with placebo, in
patients with prostate cancer, a double-blind placebo-controlled
randomized trial has shown.
The study results, presented here at the 2013 Annual Meeting of the American Society of Clinical Oncology (ASCO
®), made headlines around the world and caused the polyphenol-rich supplement, known as
Pomi-T (nature Medical Products), to sell out within hours.
This is a "promising new therapy," said Tomasz Beer, MD, professor of
medicine and director of the prostate cancer research program at the
Oregon Health and Science University in Portland, during a "highlights
of the day" session.
Read the full Medscape report
(Free sign-up may be required)